Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-19

Clinical Trial Update: Midodrine and Fludrocortisone for Vasovagal Syncope [Phase 3]

View source ↗

Summary

Phase 3 trial update for midodrine and fludrocortisone in vasovagal syncope.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludrocortisone (Fludrocortisone)
  • Midodrine (Midodrine)

Snippet

Sponsor: Tehran Heart Center | Conditions: Syncope, Vasovagal | Phase 3 | Status: UNKNOWN